Prostate Cancer Doctors

Mark S. Litwin, MD, MPH

Specialty: Bladder Cancer, Kidney Cancer, Minimally Invasive Surgery, Prostate Cancer, Testicular Cancer, Urologic Oncology

Practice Location: Urology, Westwood Adult

Chair, Department of Urology. Professor of Urology, Health Policy & Management, and Nursing. He trained at Harvard and specializes in testicular, bladder, prostate and kidney cancer. Dr. Litwin’s research focuses on improving quality of care, quality of life, and equitable access to care in urologic oncology. He created and directs IMPACT, a state-funded program that provides free medical care statewide for low-income, uninsured men with prostate cancer. He also leads several national and international research projects in prostate cancer, funded by the American Cancer Society, US Department of Defense, and Movember Foundation. He directs an NIH-funded fellowship training program in outcomes research in urologic oncology. Dr. Litwin is Founder and Co-Director of the UCLA Gender Health Program. For 14 years, he led Urologic Diseases in America, the NIH’s largest effort at documenting the burden of urologic diseases on the American people. More >

William Aronson, MD

Specialty: Prostate Cancer, General Adult Urology, Urologic Oncology

Practice Locations: Olive View UCLA Medical Center, West Los Angeles, VA Medical Center

Professor of Urology, Chief of Urology at Olive View UCLA Medical Center and Chief of Urologic Oncology, Veterans Administration West Los Angeles. His clinical specialties are Prostate Cancer and General Urology. His clinical and laboratory research focuses on treatment of advanced prostate cancer and diet and lifestyle factors for chemoprevention and treatment.

Karim Chamie, MD, MSHS

Specialty: Bladder Cancer, Clinical Trials, Kidney Cancer, Minimally Invasive Surgery, Prostate Cancer, Urologic Oncology

Practice Location: Urology, Westwood Adult

Associate Professor of Urology and Society of Urologic Oncology Fellowship Director. He attended Medical School at USC and completed Urological training at UC Davis. Dr. Chamie then completed a SUO certified fellowship in Urologic Oncology at UCLA. His primary research interests are health services research and clinical trials in bladder cancer. His clinical interests include all areas of urologic oncology, with a particular emphasis on bladder cancer and robotic surgery. More >

Arnold I. Chin, MD, PhD

Specialty: Bladder Cancer, Kidney Cancer, Minimally Invasive Surgery, Prostate Cancer, Urologic Oncology

Practice Location: Urology, Westwood Adult

Associate Professor of Urology and Medical Director, Urology-Westwood. Dr. Chin completed his M.D., Ph.D. and Urology residency training at UCLA. His clinical expertise includes urologic oncology and renal transplantation. He performs open, laparoscopic, and robotic-assisted surgeries for patients with all urologic malignancies including bladder, kidney, and prostate cancer. Dr. Chin's laboratory at the UCLA Broad Stem Cell Research Center studies the differentiation of bladder cancer and its interplay with the tumor microenvironment. The long-term goals are to develop novel therapeutic targets, immune-based platforms, and stem cell-directed therapies against cancer. Dr. Chin's research has led to an investigator-initiated clinical trial that he is leading for patients with advanced small cell-neuroendocrine bladder and prostate cancer. More >

Nicholas Donin, MD

Specialty: General Adult Urology, Urologic Oncology, Prostate Cancer, Minimally Invasive Surgery

Practice Location: Urology Center - Burbank, Urology Center - Santa Clarita

Staff Physician and Voluntary Assistant Clinical Professor of Urology. After graduating from Harvard University, he received his medical degree from Columbia University in New York City and completed his internship and residency at New York University. He then completed a 2-year Urologic Oncology Fellowship at UCLA David Geffen School of Medicine. His clinical and research interests include Urologic Oncology, minimally invasive robotic surgery for treatment of both benign and malignant urologic conditions, as well as general urology. He has authored over 30 peer-reviewed publications and 2 book chapters. He is fluent in conversational Spanish, and sees patients in the UCLA Health offices in both Santa Clarita and Burbank.

Isla Garraway, MD, PhD

Specialty: Prostate Cancer, Urologic Oncology

Practice Locations: West Los Angeles, VA Medical Center

Professor of Urology at UCLA and Director of Urologic Research, Attending Urologist, Greater Los Angeles-VA Medical Center. Dr. Garraway’s primary clinical and research focus is on prostate cancer. She is a member of the Jonsson Comprehensive Cancer Center and heads a laboratory investigating prostate development and carcinogenesis. More >

Stuart Holden, MD

Specialty: General Adult Urology, Prostate Cancer, Urologic Oncology

Practice Location: Urology, Westwood Adult

Clinical Professor of Urology and Co-Director, UCLA Institute of Urologic Oncology. Dr. Holden is recognized as an expert in prostate cancer research throughout the medical community. His dedication to patient care led to him being named medical director of the Prostate Cancer Foundation. Prior to joining UCLA, Holden was the director of the Louis Warschaw Prostate Cancer Center at Cedars-Sinai Medical Center and the first holder of the Warschaw, Robertson, Law Families Chair in Prostate Cancer. More >

Mark S. Litwin, MD, MPH

Specialty: Bladder Cancer, Kidney Cancer, Minimally Invasive Surgery, Prostate Cancer, Testicular Cancer, Urologic Oncology

Practice Location: Urology, Westwood Adult

Chair, Department of Urology. Professor of Urology, Health Policy & Management, and Nursing. He trained at Harvard and specializes in testicular, bladder, prostate and kidney cancer. Dr. Litwin’s research focuses on improving quality of care, quality of life, and equitable access to care in urologic oncology. He created and directs IMPACT, a state-funded program that provides free medical care statewide for low-income, uninsured men with prostate cancer. He also leads several national and international research projects in prostate cancer, funded by the American Cancer Society, US Department of Defense, and Movember Foundation. He directs an NIH-funded fellowship training program in outcomes research in urologic oncology. Dr. Litwin is Founder and Co-Director of the UCLA Gender Health Program. For 14 years, he led Urologic Diseases in America, the NIH’s largest effort at documenting the burden of urologic diseases on the American people. More >

Leonard S. Marks, MD

Specialty: Clinical Trials, General Adult Urology, Prostate Cancer, Urologic Oncology

Practice Location: Urology, Westwood Adult

Professor of Urology. Dr. Marks completed training at UCLA in 1978. H received an American Foundation for Urologic Diseases scholarship award and a Prostate Cancer Foundation research award. His current research interests involve prostate markers, imaging, and minimally-invasive treatments. More >

Allan Pantuck, MD, MS, FACS

Specialty: Bladder Cancer, Clinical Trials, General Adult Urology, Kidney Cancer, Prostate Cancer, Urologic Oncology

Practice Location: Urology, Westwood Adult

Professor of Urology and Vice Chair of Academic Affairs for Urology. Dr. Pantuck specializes in urologic cancers and has a long standing interest in kidney, prostate, bladder cancers, developing new treatment strategies through basic and clinical research and in the study of nutritional approaches to their prevention and treatment. More >

Robert E. Reiter, MD, MBA

Specialty: Bladder Cancer, Clinical Trials, Minimally Invasive Surgery, Prostate Cancer, Urologic Oncology

Practice Location: Urology, Westwood Adult

Professor of Urology, Professor of Molecular Biology, Chief of the Division of Urologic Oncology, Director of the Prostate Cancer Program, Bing Research Chair in Urology, Co-Director of the Genitourinary Oncology Program in UCLA's Jonsson Cancer Center. Dr. Reiter attended Stanford Medical School, completed urologic training at Stanford and Baylor College of Medicine, completed additional fellowship training in urological cancer at the National Cancer Institute. His clinical interests include all areas of urologic oncology, with an emphasis on prostate cancer. He specializes in robotically-assisted prostatectomy and cystectomy, as well as open surgery, with robotic experience dating back to 2004, for bladder, prostate, and renal malignancies. Dr. Reiter is involved in all aspects of urologic oncology, with an emphasis on prostate cancer, and brings extensive experience in robotic surgery and the applications of translational research and the latest in MRI and molecular imaging to the management of men with this disease. More >

Christopher Saigal, MD, MPH

Specialty: Bladder Cancer, General Adult Urology, Kidney Cancer, Kidney Stone and Urinary Obstructionr, Minimally Invasive Surgery, Prostate Cancer, Testicular Cancer, Urologic Oncology

Practice Locations: Urology, Westwood Adult

Professor and Executive Vice Chair of Urology. Clinical practice, UCLA Westwood Campus. He is also on the staff of the West Los Angeles Veterans Affairs Medical Center. Dr. Saigal has had a longstanding clinical interest in urologic cancers and the surgical treatment of benign prostatic hyperplasia. His research is focused on patient-centered decision support and quality of care for urologic conditions. More >